Overview
Management Team
Board of Directors
Collaborations
Careers
Overview
Picoplatin
Research
Overview
Small Cell Lung Cancer
(SCLC)
Colorectal Cancer
Prostate Cancer
Overview
Financial Info
Stock Info
Shareholder Services
Corporate Governance
Press Releases
Events
Overview
Financial Information
-
Quarterly Results
-
Annual Reports
-
SEC Filings
Stock Information
Shareholder Services
Corporate Governance
Print page
E-mail page
Annual Reports
2007 Annual Report
2006 Annual Report
2005 Annual Report
2004 Annual Report
Stock Information
PARD - (NASD)
$2.52
- 0.37
Nov 21, 2008
4:00 PM ET
Shareholder Tools
Investor Briefcase
Investor Kit
News & Event Alerts
Download Library
Glossary
Investor FAQs
News Feeds
Investor site
Section only
Quotes delayed at least 20 minutes. Information provided by eSignal.
About Poniard
|
Programs
|
Clinical Trials
|
Investors
|
News & Events
|
Contact
© 2007 Poniard Pharmaceuticals.
Terms & Conditions
|
Corporate Governance
|
Site Users Guide
